Project Number 5U01AG053247-03 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator IVES, JEFFREY L Principal Investigator First Name JEFFREY L Principal Investigator Last Name IVES Awardee Organization ACUMEN PHARMACEUTICALS, INC. Awardee State Virginia Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-15-174: Alzheimer's Drug-Development Program (U01) FY Overall Cost $1,135,517 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA
